April 9 (Reuters) - A U.S. district court has entered into what is known as a consent decree to restrict the production and sale of Philips' new sleep apnea machines and other devices at several facilities in the country until certain requirements are met, the U.S. Food and Drug Administration said on Tuesday. (Reporting by Christy Santhosh; Editing by Maju Samuel)
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
24.09 EUR | +2.51% | -2.90% | +15.22% |
05-07 | PHILIPS : Jefferies remains negative, but raises its target | CF |
05-07 | PHILIPS NV : Jefferies remains a Sell rating | ZD |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.22% | 23.66B | |
+8.07% | 219B | |
+7.87% | 185B | |
+12.75% | 135B | |
-1.37% | 62.21B | |
+4.88% | 51.01B | |
+11.59% | 51.28B | |
+2.71% | 41.85B | |
+4.90% | 37.02B | |
+23.75% | 31.27B |
- Stock Market
- Equities
- PHIA Stock
- News Philips NV
- Federal court enters agreement to restrict production of new Philips' sleep apnea devices